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Better surveillance to protect mothers and infants from Zika
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In The Lancet Infectious Diseases, Sarah Hill and colleagues1 report their multi-component 
investigation of the Zika virus outbreak in Angola. The authors make a compelling argument 
that the Asian lineage of Zika virus caused the outbreak, recognition of which was 
substantially delayed. Phylogenetic analyses of the viral genome suggest that isolates from 
Angola were closely related to Zika viruses circulating in Brazil, and that the virus was 
introduced to Angola between July, 2015, and June, 2016. They estimated that Zika virus 
had been circulating in Angola for 17–28 months, and reported that the virus could have 
been circulating for up to 18 months before local detection in December, 2016 (local 
transmission of Zika virus was reported to WHO in January, 2017).1,2 The timing of the 
birth of the first infant with suspected microcephaly that was potentially attributable to Zika 
virus infection in January, 2017, provides additional evidence that the virus was probably 
circulating in early 2016.3,4 Such delays in recognition of Zika virus are not unusual in 
countries with little surveillance of arboviral diseases or birth defects. For Zika virus, the 
absence of adequate surveillance could lead to severe consequences—specifically, infants 
with congenital Zika syndrome.
Surveillance of transmission of Zika virus is difficult because most cases are mild or 
asymptomatic; clinical signs and symptoms, when present, are similar to those of other 
common infections; and there is no reliable diagnostic test outside the 1–2 weeks after initial 
infection.5 Careful genomic epidemiological studies in the WHO Region of the Americas 
have shown probable prolonged local transmission and multiple introductions of Zika virus 
before detection even in areas with well established arboviral surveillance systems,6,7 
emphasising the challenge facing countries with less developed surveillance, particularly 
those with close travel and trade links with countries where Zika virus or other arboviruses 
are circulating.
The 2015–16 Zika virus outbreak in the Americas also showed the devastating fetal effects 
associated with the Asian lineage of Zika virus. Animal studies8 suggest that the African 
lineage, which was identified in Uganda more than 70 years ago and has probably been 
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circulating across the continent since, could be equally or more harmful to the developing 
fetus. However, the absence of surveillance for both the virus and adverse pregnancy 
outcomes in most African countries means that potential effects of Zika virus infection could 
have gone undetected for decades.8 A 2006 March of Dimes report9 on the global burden of 
birth defects estimated that Angola had one of the highest prevalences of birth defects 
worldwide. Because there is no surveillance infrastructure for birth and few health-care 
personnel trained in public health surveillance, affected babies in Angola are unlikely to be 
detected or to receive appropriate care.
To improve capacity for surveillance of birth defects, the US Centers for Disease Control 
and Prevention (CDC), the International Clearinghouse for Birth Defects Surveillance and 
Research, ministries of health, and other relevant country-specific government entities have 
collaborated on in-country and regional training. This training has focused on increasing 
awareness of the importance of birth defects surveillance; the establishment of a programme 
to collect complete, accurate, and timely data; and ensuring referral to services to improve 
quality of life for children affected by birth defects. Training materials, including a 
surveillance manual and an atlas of selected congenital anomalies, to help countries to 
launch surveillance programmes and monitor birth defects in low-income and middle-
income countries are publicly available.
Development, implementation, and maintenance of high-quality surveillance of birth defects 
and vector-borne disease are difficult and costly, but can aid in the timely detection of new 
and emerging threats to mothers and babies, as proven by experience with Zika virus. Both 
the African and Asian lineage of the virus could have been causing harm undetected for the 
past 50 years. Some settings in the Americas had surveillance infrastructures that were well 
positioned to identify and respond to the 2015–16 outbreak, thereby facilitating rapid 
understanding of the effect of the Asian lineage on the health of mothers and babies. 
Knowledge gleaned from the outbreak in the Americas has informed care and clinical 
management of pregnant women and children, and guidance for travellers. Both the US 
CDC and WHO advise counselling—with careful consideration of the risks, benefits, and 
the individual travel situation—for any pregnant women considering travel to an area where 
these is a risk of Zika virus infection.10,11 Both organisations also recommend that pregnant 
women avoid travel to areas with Zika outbreaks and recommend caution about or avoidance 
of travel to areas with current or past Zika virus transmission.10,11 Transmission of Zika 
virus in these settings is difficult to predict in the absence of robust surveillance and testing. 
By the time an outbreak is detected, pregnant women and their developing babies might have 
already have been exposed to Zika virus, as shown by the experience documented in Angola.
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For the International Clearinghouse for Birth Defects Surveillance and Research see 
margin link to www.icbdsr.org
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For training materials see http://www.who.int/nutrition/publications/
birthdefects_manual/en/
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